GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Other Current Liabilities

OKUR (OnKure Therapeutics) Other Current Liabilities : $2.36 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Other Current Liabilities?

OnKure Therapeutics's other current liabilities for the quarter that ended in Sep. 2024 was $2.36 Mil.

OnKure Therapeutics's quarterly other current liabilities increased from Mar. 2024 ($0.59 Mil) to Jun. 2024 ($1.71 Mil) and increased from Jun. 2024 ($1.71 Mil) to Sep. 2024 ($2.36 Mil).

OnKure Therapeutics's annual other current liabilities increased from . 20 ($0.00 Mil) to Dec. 2022 ($1.46 Mil) and increased from Dec. 2022 ($1.46 Mil) to Dec. 2023 ($1.66 Mil).

OnKure Therapeutics Other Current Liabilities Historical Data

The historical data trend for OnKure Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Other Current Liabilities Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23
Other Current Liabilities
- -

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Liabilities Get a 7-Day Free Trial - - - - -

OnKure Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

OnKure Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

OnKure Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Other Current Liabilities
Comparable Companies
CAMP LCTX OSTX ABOS CABA LPTX CSBR INMB MIST XBIT VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
Website
https://www.onkuretherapeutics.com
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.